Literature DB >> 29203573

Mechanisms of β-cell dedifferentiation in diabetes: recent findings and future research directions.

Mohammed Bensellam1,2, Jean-Christophe Jonas2, D Ross Laybutt1,3.   

Abstract

Like all the cells of an organism, pancreatic β-cells originate from embryonic stem cells through a complex cellular process termed differentiation. Differentiation involves the coordinated and tightly controlled activation/repression of specific effectors and gene clusters in a time-dependent fashion thereby giving rise to particular morphological and functional cellular features. Interestingly, cellular differentiation is not a unidirectional process. Indeed, growing evidence suggests that under certain conditions, mature β-cells can lose, to various degrees, their differentiated phenotype and cellular identity and regress to a less differentiated or a precursor-like state. This concept is termed dedifferentiation and has been proposed, besides cell death, as a contributing factor to the loss of functional β-cell mass in diabetes. β-cell dedifferentiation involves: (1) the downregulation of β-cell-enriched genes, including key transcription factors, insulin, glucose metabolism genes, protein processing and secretory pathway genes; (2) the concomitant upregulation of genes suppressed or expressed at very low levels in normal β-cells, the β-cell forbidden genes; and (3) the likely upregulation of progenitor cell genes. These alterations lead to phenotypic reconfiguration of β-cells and ultimately defective insulin secretion. While the major role of glucotoxicity in β-cell dedifferentiation is well established, the precise mechanisms involved are still under investigation. This review highlights the identified molecular mechanisms implicated in β-cell dedifferentiation including oxidative stress, endoplasmic reticulum (ER) stress, inflammation and hypoxia. It discusses the role of Foxo1, Myc and inhibitor of differentiation proteins and underscores the emerging role of non-coding RNAs. Finally, it proposes a novel hypothesis of β-cell dedifferentiation as a potential adaptive mechanism to escape cell death under stress conditions.
© 2018 Society for Endocrinology.

Entities:  

Keywords:  dedifferentiation; diabetes; glucotoxicity; islet; β-cell

Mesh:

Year:  2017        PMID: 29203573     DOI: 10.1530/JOE-17-0516

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  66 in total

Review 1.  β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes.

Authors:  Laura I Hudish; Jane Eb Reusch; Lori Sussel
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

2.  Macrophage alterations in islets of obese mice linked to beta cell disruption in diabetes.

Authors:  Jeng Yie Chan; Kailun Lee; Emma L Maxwell; Cassandra Liang; D Ross Laybutt
Journal:  Diabetologia       Date:  2019-03-04       Impact factor: 10.122

3.  [Effects of glycosylated hemoglobin and disease course on islet β-cell function in patients with type 2 diabetes].

Authors:  H E Yinhui; X U Haiyan; F U Qi; Yang Tao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-09-30

Review 4.  Inadequate β-cell mass is essential for the pathogenesis of type 2 diabetes.

Authors:  Gordon C Weir; Jason Gaglia; Susan Bonner-Weir
Journal:  Lancet Diabetes Endocrinol       Date:  2020-01-29       Impact factor: 32.069

Review 5.  Epigenetics in β-cell adaptation and type 2 diabetes.

Authors:  Hyunki Kim; Rohit N Kulkarni
Journal:  Curr Opin Pharmacol       Date:  2020-11-21       Impact factor: 5.547

6.  Protein Kinases Signaling in Pancreatic Beta-cells Death and Type 2 Diabetes.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Phosphorylation of Forkhead Protein FoxO1 at S253 Regulates Glucose Homeostasis in Mice.

Authors:  Kebin Zhang; Xiaoqin Guo; Hui Yan; Yuxin Wu; Quan Pan; James Zheng Shen; Xiaopeng Li; Yunmei Chen; Ling Li; Yajuan Qi; Zihui Xu; Wei Xie; Weiping Zhang; David Threadgill; Ling He; Daniel Villarreal; Yuxiang Sun; Morris F White; Hongting Zheng; Shaodong Guo
Journal:  Endocrinology       Date:  2019-05-01       Impact factor: 4.736

Review 8.  Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure.

Authors:  Décio L Eizirik; Lorenzo Pasquali; Miriam Cnop
Journal:  Nat Rev Endocrinol       Date:  2020-05-12       Impact factor: 43.330

9.  Expansion of Islet-Resident Macrophages Leads to Inflammation Affecting β Cell Proliferation and Function in Obesity.

Authors:  Wei Ying; Yun Sok Lee; Yi Dong; Jason S Seidman; Meixiang Yang; Roi Isaac; Jong Bae Seo; Bi-Huei Yang; Joshua Wollam; Matthew Riopel; Joanne McNelis; Christopher K Glass; Jerrold M Olefsky; Wenxian Fu
Journal:  Cell Metab       Date:  2018-12-27       Impact factor: 27.287

10.  Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.

Authors:  Mohammed Bensellam; Yan-Chuan Shi; Jeng Yie Chan; D Ross Laybutt; Heeyoung Chae; Michel Abou-Samra; Evan G Pappas; Helen E Thomas; Patrick Gilon; Jean-Christophe Jonas
Journal:  Diabetologia       Date:  2019-10-17       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.